Being free of Europe means faster drug approvals, says new Novartis UK chief
Being free of Europe means faster drug approvals, says new Novartis UK chief Chinmay Bhatt believes Brexit can boost Britain's healthcare industry, but says barriers remain for patients and suppliers 4 February 2021 • 6:00am In the throes of a global pandemic, it’s difficult to appreciate any silver livings to the way Covid has transformed our lives. But for pharmaceutical companies, and the wider health and life sciences sector, the virus has forced the industry to work faster, more efficiently and more collaboratively. This has culminated in vaccines being discovered, developed and deli...